Singapore markets close in 1 hour 25 minutes
Straits Times Index
3,304.86 -17.22 (-0.52%) Nikkei
39,134.79 +96.63 (+0.25%) Hang Seng
18,158.18 -208.77 (-1.14%) FTSE 100
8,245.46 +16.98 (+0.21%) Bitcoin USD
67,784.94 -1,623.79 (-2.34%) CMC Crypto 200
1,402.81 -38.83 (-2.69%)
PFE Dec 2024 26.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:12PM EDT. Market open.
| Previous close | 3.2000 |
| Open | 3.2000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 26.00 |
| Expiry date | 2024-12-20 |
| Day's range | 3.2000 - 3.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
ZacksPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksGSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
© 2024 Yahoo. All rights reserved.